Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brianna L Norton

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Infection and Drug Resistance|December 11, 2012
Current management options for latent tuberculosis: a reviewBrianna L Norton, David P Holland
Infectious Disease Clinics of North America|May 21, 2018
Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best PracticeBrianna L Norton, Matthew J Akiyama, Philippe J Zamor, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|October 29, 2013
Barriers to using text message appointment reminders in an HIV clinicBrianna L Norton, Anna K Person, Catherine Castillo, et al.
Open Forum Infectious Diseases|November 2, 2020
Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral AgentsBrianna L Norton, Matthew J Akiyama, Linda Agyemang, et al.
The International Journal on Drug Policy|March 5, 2021
High HCV cure rates among people who inject drugs and have suboptimal adherence: A patient-centered approach to HCV models of careBrianna L Norton, Matthew J Akiyama, Julia H Arnsten, et al.
Annals of Internal Medicine|April 9, 2019
Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled TrialMatthew J Akiyama, Brianna L Norton, Julia H Arnsten, et al.
AIDS Care|September 17, 2021
HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapyHadi J Minhas, Matthew J Akiyama, Brianna L Norton, et al.
AIDS Patient Care and Stds|August 7, 2012
Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfectionBrianna L Norton, Lawrence Park, Leah J McGrath, et al.
BMC Infectious Diseases|December 5, 2020
Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trialIrene Pericot-Valverde, Moonseong Heo, Matthew J Akiyama, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 26, 2016
No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based ScreeningBrianna L Norton, William N Southern, Meredith Steinman, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Infection and Drug Resistance|December 11, 2012
Current management options for latent tuberculosis: a reviewBrianna L Norton, David P Holland
Infectious Disease Clinics of North America|May 21, 2018
Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best PracticeBrianna L Norton, Matthew J Akiyama, Philippe J Zamor, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|October 29, 2013
Barriers to using text message appointment reminders in an HIV clinicBrianna L Norton, Anna K Person, Catherine Castillo, et al.
Open Forum Infectious Diseases|November 2, 2020
Low Adherence Achieves High HCV Cure Rates Among People Who Inject Drugs Treated With Direct-Acting Antiviral AgentsBrianna L Norton, Matthew J Akiyama, Linda Agyemang, et al.
The International Journal on Drug Policy|March 5, 2021
High HCV cure rates among people who inject drugs and have suboptimal adherence: A patient-centered approach to HCV models of careBrianna L Norton, Matthew J Akiyama, Julia H Arnsten, et al.
Annals of Internal Medicine|April 9, 2019
Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled TrialMatthew J Akiyama, Brianna L Norton, Julia H Arnsten, et al.
AIDS Care|September 17, 2021
HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapyHadi J Minhas, Matthew J Akiyama, Brianna L Norton, et al.
AIDS Patient Care and Stds|August 7, 2012
Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfectionBrianna L Norton, Lawrence Park, Leah J McGrath, et al.
BMC Infectious Diseases|December 5, 2020
Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trialIrene Pericot-Valverde, Moonseong Heo, Matthew J Akiyama, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 26, 2016
No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based ScreeningBrianna L Norton, William N Southern, Meredith Steinman, et al.
Pageof 6